Boston Scientific (BSX)

Total Non-Current Liabilities

$13.62B

Quarterly · Period ending: · USD

BSX logo

BSX Total Non-Current Liabilities

Latest reported$13.62B
BSX Quarterly Total Non-Current Liabilities ($21.40M → $13.62B)
High-resolution chart · PNG

BSX total non-current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Boston Scientific Total Non-Current Liabilities — Quarterly (USD)
Period endingTotal Non-Current Liabilities (USD)
13,616,000,000
13,676,000,000
13,762,000,000
13,749,000,000
13,716,000,000
12,636,000,000
10,993,000,000
11,212,000,000
10,922,000,000
11,585,000,000
10,673,000,000
10,335,000,000
10,554,000,000
10,700,000,000
11,093,000,000
10,758,000,000
11,055,000,000
11,327,000,000
11,333,000,000
11,393,000,000
11,153,000,000
11,788,000,000
11,770,000,000
11,979,000,000
12,099,000,000
12,333,000,000
11,822,000,000
12,803,000,000
10,034,000,000
10,090,000,000
7,013,000,000
7,008,000,000
7,118,000,000
7,184,000,000
6,376,000,000
6,220,000,000
6,847,000,000
7,400,000,000
7,776,000,000
8,199,000,000
8,436,000,000
8,653,000,000
9,383,000,000
9,567,000,000
8,606,000,000
7,508,000,000
7,741,000,000
8,197,000,000
8,160,000,000
8,082,000,000
8,371,000,000
8,452,000,000
7,916,000,000
8,624,000,000
8,512,000,000
8,310,000,000
8,298,000,000
8,120,000,000
8,130,000,000
8,094,000,000
8,127,000,000
8,661,000,000
8,223,000,000
8,493,000,000
8,403,000,000
9,159,000,000
9,854,000,000
9,906,000,000
10,029,000,000
10,398,000,000
10,732,000,000
10,598,000,000
11,231,000,000
11,562,000,000
12,850,000,000
12,441,000,000
12,494,000,000
13,150,000,000
13,168,000,000
13,286,000,000
13,552,000,000
2,403,000,000
2,435,000,000
3,033,000,000
2,110,000,000
1,645,000,000
1,540,000,000
2,107,000,000
2,142,000,000
882,000,000
1,444,000,000
1,188,000,000
1,162,000,000
1,045,000,000
1,060,000,000
947,000,000
961,000,000
1,024,000,000
1,128,000,000
959,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.